Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Gets Quality Certification in US, Europe, and Japan

NEW YORK, May 18 (GenomeWeb News) - Hybrigenics, a Paris-based, a protein pathways-analysis company, has received global quality certification for its proteomics services, a public relations firm representing the firm said today.


According to Andrew Lloyd, the firm's spokesperson, Hybrigenics' services have obtained ISO 9001-2000 certification from the International Standards Organization in Europe, as well as certification from QMI, the standards registrar in the US, and from the Japan Quality Assurance Association, a non-profit standards registrar in that country.


Bart Kwist, the company's CEO, said the certifications would provide customers with "added confidence in the quality of the protein data" that the proteomics service provides. He said that few biotech companies have achieved such certification and that it would make Hybrigenics more competitive.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.